Factors affecting pathological complete response in locally advanced breast cancer cases receiving neoadjuvant therapy: A comprehensive literature review
M Alamoodi - European journal of breast health, 2023 - pmc.ncbi.nlm.nih.gov
Determining pathological complete response (pCR) could be an important step in planning
individual treatment, hence improving the prognosis in terms of survival. Achieving breast …
individual treatment, hence improving the prognosis in terms of survival. Achieving breast …
Potential biomarkers in breast cancer drug development: application of the biomarker qualification evidentiary framework
E Wang, M Henderson, P Yalamanchili… - Biomarkers in …, 2024 - Taylor & Francis
Breast cancer treatments have evolved rapidly, and clinically meaningful biomarkers have
been used to guide therapy. These biomarkers hold utility within the drug development …
been used to guide therapy. These biomarkers hold utility within the drug development …
Early assessment of shear wave elastography parameters foresees the response to neoadjuvant chemotherapy in patients with invasive breast cancer
Background Early prediction of tumor response to neoadjuvant chemotherapy (NACT) is
crucial for optimal treatment and improved outcome in breast cancer patients. The purpose …
crucial for optimal treatment and improved outcome in breast cancer patients. The purpose …
A nomogram to predict the pathologic complete response of neoadjuvant chemotherapy in triple-negative breast cancer based on simple laboratory indicators
F Zhang, M Huang, H Zhou, K Chen, J Jin, Y Wu… - Annals of surgical …, 2019 - Springer
Background Triple-negative breast cancer (TNBC) patients who achieve a pathologic
complete response (pCR) after neoadjuvant chemotherapy (NAC) have better prognoses …
complete response (pCR) after neoadjuvant chemotherapy (NAC) have better prognoses …
Radioproteomics in breast cancer: prediction of Ki-67 expression with MRI-based radiomic models
Y Kayadibi, B Kocak, N Ucar, YN Akan, P Akbas… - Academic …, 2022 - Elsevier
Rationale and Objectives We aimed to investigate the value of magnetic resonance image
(MRI)-based radiomics in predicting Ki-67 expression of breast cancer. Methods In this …
(MRI)-based radiomics in predicting Ki-67 expression of breast cancer. Methods In this …
Radiation dermatitis and pneumonitis in patients irradiated for breast cancer
MC Eggert, NY Yu, D Rades - in vivo, 2023 - iv.iiarjournals.org
Background/Aim: Adjuvant radiotherapy (RT) for breast cancer can be associated with acute
dermatitis (ARD) and pneumonitis (RP). Prevalence and risk factors were characterized …
dermatitis (ARD) and pneumonitis (RP). Prevalence and risk factors were characterized …
Developing a prediction model for pathologic complete response following neoadjuvant chemotherapy in breast cancer: a comparison of model building approaches
RB Basmadjian, S Kong, DJ Boyne… - JCO Clinical Cancer …, 2022 - ascopubs.org
PURPOSE The optimal characteristics among patients with breast cancer to recommend
neoadjuvant chemotherapy is an active area of clinical research. We developed and …
neoadjuvant chemotherapy is an active area of clinical research. We developed and …
[HTML][HTML] Transcriptome analysis identifies GATA3-AS1 as a long noncoding RNA associated with resistance to neoadjuvant chemotherapy in locally advanced breast …
Breast cancer is one of the leading causes of mortality in women worldwide, neoadjuvant
chemotherapy has emerged as an option for the management of locally advanced breast …
chemotherapy has emerged as an option for the management of locally advanced breast …
Prognostic analysis of three forms of Ki‐67 in patients with breast cancer with non‐pathological complete response before and after neoadjuvant systemic treatment
W Zhang, Y Xu, Y Wang, J He, R Chen, X Wan… - Cancer …, 2023 - Wiley Online Library
Background Patients who do not achieve a pathological complete response (pCR) after
neoadjuvant systemic treatment (NST) have a significantly worse prognosis. A reliable …
neoadjuvant systemic treatment (NST) have a significantly worse prognosis. A reliable …
Ultrasound Strain Elastography and Contrast‐Enhanced Ultrasound in Predicting the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer: A Nomogram …
Q Liu, L Tang, M Chen - Journal of Ultrasound in Medicine, 2022 - Wiley Online Library
Objectives To explore whether conventional elastography and contrast‐enhanced
ultrasound (CEUS) combined with histopathology can monitor the efficacy of neoadjuvant …
ultrasound (CEUS) combined with histopathology can monitor the efficacy of neoadjuvant …